481 related articles for article (PubMed ID: 18971270)
1. Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells.
Guo H; Jiang D; Ma D; Chang J; Dougherty AM; Cuconati A; Block TM; Guo JT
J Virol; 2009 Jan; 83(2):847-58. PubMed ID: 18971270
[TBL] [Abstract][Full Text] [Related]
2. DNA-dependent activator of interferon-regulatory factors inhibits hepatitis B virus replication.
Chen QY; Liu YH; Li JH; Wang ZK; Liu JX; Yuan ZH
World J Gastroenterol; 2012 Jun; 18(22):2850-8. PubMed ID: 22719196
[TBL] [Abstract][Full Text] [Related]
3. Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates innate immune signaling to suppress virus replication.
Lu HL; Liao F
J Immunol; 2013 Sep; 191(6):3264-76. PubMed ID: 23926323
[TBL] [Abstract][Full Text] [Related]
4. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.
Liu Y; Li J; Chen J; Li Y; Wang W; Du X; Song W; Zhang W; Lin L; Yuan Z
J Virol; 2015 Feb; 89(4):2287-300. PubMed ID: 25505063
[TBL] [Abstract][Full Text] [Related]
6. TLRs antiviral effect on hepatitis B virus in HepG2 cells.
Xia C; Lu M; Zhang Z; Meng Z; Zhang Z; Shi C
J Appl Microbiol; 2008 Nov; 105(5):1720-7. PubMed ID: 19149768
[TBL] [Abstract][Full Text] [Related]
7. Early inhibition of hepatocyte innate responses by hepatitis B virus.
Luangsay S; Gruffaz M; Isorce N; Testoni B; Michelet M; Faure-Dupuy S; Maadadi S; Ait-Goughoulte M; Parent R; Rivoire M; Javanbakht H; Lucifora J; Durantel D; Zoulim F
J Hepatol; 2015 Dec; 63(6):1314-22. PubMed ID: 26216533
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
9. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy.
Chang J; Block TM; Guo JT
Antiviral Res; 2012 Dec; 96(3):405-13. PubMed ID: 23072881
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation.
Lin S; Wu M; Xu Y; Xiong W; Yi Z; Zhang X; Zhenghong Y
Biochim Biophys Acta; 2007 Oct; 1772(10):1150-7. PubMed ID: 17935950
[TBL] [Abstract][Full Text] [Related]
12. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes.
Sarkar N; Panigrahi R; Pal A; Biswas A; Singh SP; Kar SK; Bandopadhyay M; Das D; Saha D; Kanda T; Sugiyama M; Chakrabarti S; Banerjee A; Chakravarty R
J Viral Hepat; 2015 Oct; 22(10):817-27. PubMed ID: 25720442
[TBL] [Abstract][Full Text] [Related]
13. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes.
Zhang Z; Filzmayer C; Ni Y; Sültmann H; Mutz P; Hiet MS; Vondran FWR; Bartenschlager R; Urban S
J Hepatol; 2018 Jul; 69(1):25-35. PubMed ID: 29524530
[TBL] [Abstract][Full Text] [Related]
15. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.
Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF
Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.
Mao R; Nie H; Cai D; Zhang J; Liu H; Yan R; Cuconati A; Block TM; Guo JT; Guo H
PLoS Pathog; 2013; 9(7):e1003494. PubMed ID: 23853601
[TBL] [Abstract][Full Text] [Related]
19. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
20. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
Front Immunol; 2021; 12():745802. PubMed ID: 34671360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
